TGTR TLV Week ended 31 Jul 2026

Weekly Investor Report

Together Pharma Ltd · Healthcare · Drug Manufacturers - Specialty & Generic

Open interactive chart View report data
Latest close 2.33 ILA
2.4% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -98.9% below the Trend Line and sits at 0.0% of its 52-week range. The latest completed week returned 2.4%, after a -0.4% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.

Setup score 15 out of 100
Latest Close 2.33 ILA 31 Jul 2026
1W Return 2.4% latest completed week
4W Return -0.4% short-term follow-through
12W Return -99.1% quarterly tape
Trend Breadth 0.0% 0 of 52 weeks active
Volume Ratio 0.7x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 2.4% Latest completed week; four-week move -0.4%. Indicator stack 0/32 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 37.56% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 50/100 3 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -98.9% below the Trend Line and sits at 0.0% of its 52-week range. The latest completed week returned 2.4%, after a -0.4% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0812-week average 0.06

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.08Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -0.4% over four weeks, -99.1% over 12 weeks, and -99.4% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W2.4%
4W-0.4%
12W-99.1%
26W-99.3%
52W-99.4%
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-1.11Latest activity-pressure read.
Pressure change23.8%Four-week change in activity pressure.
Leadership-99.26Latest relative-leadership reading.
RS change0.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 3 relevant articles.

0 positive · 3 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-99.4%Distance below the 52-week high.
13-week volatility26.3%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher8 of 2618 weeks finished lower.
Best week+4.7%Week of 24 Apr.
Worst week-99.1%Week of 5 Jun.
Latest week+2.4%Week of 31 Jul.

Shape of recent returns

Strong gains1
Modest gains7
Flat weeks0
Modest losses16
Sharp losses2
Recent vol26.3%13-week weekly-return volatility.
Base vol13.8%52-week weekly-return volatility.
Up/down split18/34Count of positive and negative weeks in the 52-week window.
Average skew2.1% / -5.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape16/100

Trend, activity pressure, participation, and risk combine to a 16/100 tape read.

 Indicator analysis10/100

Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.

Activity pressure 0.08; No reversal markers Next-Week ExpectancyNegative 37.56%

Next-week expectancy is negative with a 37.56% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100

No published factor snapshot is available yet.

 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

Weighted news tone is neutral across 3 relevant articles.

Together Pharma sells first medical cannabis in Germany - Globes Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20262.33 ILA2.4%211.8 ILA380.5 ILA-1.11-99.2614.8KOff
24 Jul 20262.27 ILA0.6%222.8 ILA382.6 ILA-1.06-99.3112.7KOff
17 Jul 20262.26 ILA-3.6%233.8 ILA384.3 ILA-1.17-99.3219.9KOff
10 Jul 20262.35 ILA0.3%244.7 ILA386.1 ILA-1.29-99.3036.7KOff
3 Jul 20262.34 ILA0.1%255.9 ILA387.8 ILA-1.45-99.3347.9KOff
26 Jun 20262.33 ILA1.9%267.4 ILA389.5 ILA-1.61-99.340Off
19 Jun 20262.29 ILA-0.6%278.9 ILA391.2 ILA-1.58-99.3917.2KOff
12 Jun 20262.31 ILA0.3%290.3 ILA392.8 ILA-1.55-99.435.7KOff
5 Jun 20262.30 ILA-99.1%301.4 ILA394.6 ILA-1.48-99.441.6KOff
29 May 2026244.3 ILA-3.4%312.3 ILA396.4 ILA-1.27-44.3331.8KOff
22 May 2026253.0 ILA-3.8%314.7 ILA396.5 ILA-1.12-42.574.0KOff
15 May 2026262.9 ILA-1.8%317.5 ILA396.6 ILA-1.03-41.2811.2KOff
8 May 2026267.6 ILA-0.2%320.9 ILA396.7 ILA-0.94-43.0054.5KOff
1 May 2026268.2 ILA-3.8%324.0 ILA396.7 ILA-1.08-42.7155.9KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.